Science Explorer Interactive view Map
Company · Munich · Germany

Amgen (Germany)

World rank, all time
#17,840
of 42,892
Rank in Germany
#871
of 2,077
Research works
149
▼ 3% vs 2013–17
Citations
4.5k
29.8 per fractional work
Top-10% rate
16.1%
record average 16.5%
Open access
44%
world 28%

What does Amgen (Germany) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.4× the share of its output that it takes of world research.

  1. MedicineField · 20.4 works3.4×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.15× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.18× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 8.50× its world share, 3 worksImmunology and Micro…Chemistry: 1.18× its world share, 1 worksChemistryComputer Science: 0.21× its world share, 0 worksComputer ScienceEngineering: 0.12× its world share, 1 worksEngineeringEnvironmental Science: 0.08× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.30× its world share, 0 worksMaterials ScienceMathematics: 0.60× its world share, 0 worksMathematicsHealth Professions: 0.52× its world share, 0 worksHealth ProfessionsMedicine: 3.36× its world share, 20 worksMedicineDecision Sciences: 0.73× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.53× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.13× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 8.5×. Every wedge is a field page.

Who are the top researchers at Amgen (Germany)?

Ranked on the composite score, Gerhard Zugmaier and Peter Kufer lead among researchers whose main affiliation is Amgen (Germany).

  1. 1 Gerhard Zugmaier Germany · #244,736 worldwide 122 citations · 26 works
  2. 2 Peter Kufer Germany · #587,993 worldwide 76 citations · 17 works
All ranked researchers at Amgen (Germany)

Which keywords describe research at Amgen (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Clinical Trials, Cancer Immunotherapy, Monoclonal Antibodies, Lymphoma, CAR T Cells, Chimeric Antigen Receptor and Glycosylation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Immunotherapy4▲ 19×5 topics
  2. Clinical Trials4▲ 18×7 topics
  3. Cancer Immunotherapy3▲ 70×2 topics
  4. Monoclonal Antibodies3▲ 106×3 topics
  5. Lymphoma3▲ 57×2 topics
  6. CAR T Cells3▲ 118×1 topic
  7. Chimeric Antigen Receptor3▲ 118×1 topic
  8. Glycosylation3▲ 78×2 topics
  9. Minimal Residual Disease2▲ 114×2 topics
  10. Targeted Therapy2▲ 35×5 topics
  11. Antibody Engineering2▲ 126×1 topic
  12. Fc Receptors2▲ 126×1 topic
  13. Therapeutic Antibodies2▲ 102×2 topics
  14. Prognostic Factors2▲ 15×6 topics
  15. Biomarkers2▲ 8.2×4 topics
  16. Staging System2▲ 91×2 topics
  17. Diagnosis Criteria2▲ 155×1 topic
  18. International Myeloma Working Group2▲ 155×1 topic
  19. Chemotherapy2▲ 6.8×6 topics
  20. Genomic Profiling1▲ 43×2 topics
  21. Tumor Microenvironment1▲ 9.7×2 topics
  22. Genetic Variants1▲ 21×4 topics
  23. Immunogenicity1▲ 85×3 topics
  24. Quality of Life1▲ 2.2×4 topics

Which research topics does Amgen (Germany) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Multiple Myeloma Research and Treatments and Lung Cancer Research Studies.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 Multiple Myeloma Research and Treatments Hematology 2 works
  4. 4 Lung Cancer Research Studies Oncology 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  7. 7 Lipoproteins and Cardiovascular Health Surgery 1 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 1 works
  9. 9 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
  10. 10 Immunotherapy and Immune Responses Immunology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.2%not open55.8%

World: 28% of research is openly available.

with international co-authors72.2%domestic only27.8%

World: 19% is written across borders.

How has Amgen (Germany)'s research output changed?

Output in 2018–2022 was 3% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Munich

All research institutions in Munich

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.